INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT)

Historical Holders from Q3 2018 to Q3 2025

Type / Class
Equity / IBD BREAKOUT
Symbol
BOUT
Price per share
$39.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
71,340
Total reported value
$2,777,337
% of total 13F portfolios
0%
Share change
+10,769
Value change
+$419,760
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) has 16 institutional shareholders filing 13F forms. They hold 71,340 shares. .

Institutional Holders of INNOVATOR ETFS TRUST - IBD BREAKOUT (BOUT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 71,340 $2,777,337 +$419,760 $38.97 16
2025 Q2 60,571 $2,215,212 -$588,663 $36.57 18
2025 Q1 100,924 $3,661,142 +$33,375 $36.27 15
2024 Q4 101,504 $3,958,448 -$339,032 $39.07 15
2024 Q3 66,653 $2,438,377 +$105,424 $36.58 9
2024 Q2 64,080 $2,230,477 +$675,686 $34.80 10
2024 Q1 44,666 $1,622,469 -$63,310 $36.33 8
2023 Q4 46,443 $1,535,874 +$1,196,672 $33.08 11
2023 Q3 10,264 $311,699 +$88,642 $30.36 9
2023 Q2 7,342 $237,089 -$764,394 $32.26 7
2023 Q1 32,401 $1,009,875 -$275,159 $31.16 9
2022 Q4 41,601 $1,230,079 -$1,167,798 $29.58 8
2022 Q3 83,158 $2,406,172 -$957,834 $28.05 10
2022 Q2 116,948 $3,525,050 +$1,151,493 $30.15 12
2022 Q1 66,460 $2,518,832 +$231,805 $37.91 14
2021 Q4 59,770 $2,313,422 +$104,049 $38.71 12
2021 Q3 57,431 $1,967,435 -$845,889 $34.26 12
2021 Q2 82,750 $2,753,853 -$2,948,593 $33.31 11
2021 Q1 171,929 $5,692,039 +$4,942,534 $33.11 17
2020 Q4 22,651 $715,450 -$123,050 $31.58 9
2020 Q3 41,794 $986,000 -$339,704 $23.59 10
2020 Q2 56,769 $1,260,000 +$317,657 $22.22 11
2020 Q1 42,457 $779,000 -$307,506 $18.37 8
2019 Q4 66,149 $1,385,000 -$1,073,016 $20.94 10
2019 Q3 88,333 $1,732,000 +$516,623 $19.59 9
2019 Q2 59,844 $1,258,000 -$883,000 $21.01 6
2019 Q1 106,331 $2,143,000 -$790,342 $20.14 8
2018 Q4 150,366 $2,615,000 -$175,514 $17.39 6
2018 Q3 160,466 $3,959,000 +$3,348,997 $24.67 4